SEP 14, 2017 12:00 PM PDT

How to deploy a portable lab for the surveillance of emerging infectious diseases

Speakers
  • Research Fellow, University of Birmingham
    Biography
      Josh is a molecular biologist finishing up his PhD at the University of Birmingham. He is a member of Nick Loman's lab which explores the use of cutting-edge genomics and metagenomics approaches to the diagnosis, treatment and surveillance of infectious disease. In 2015 during the West-African Ebola virus outbreak he travelled to Guinea with a 'lab-in-a-suitcase' to establish a sequencing laboratory to perform genome sequencing of new cases in a matter of days. Last year, over the course of three trips to Brazil, he developed a multiplex version of the tiling-amplicon approach used previously leading to the first successful sequencing of Zika virus genomes directly from clinical samples. This was successfully used by the ZiBRA consortium and other groups investigating the origins of Zika virus in the Americas. Most recently, as part of a group of developers known as the Nanopore WGS consortium, he showed it was possible to sequence extremely long reads on the MinION using optimized extraction and rapid sequencing protocols. Generating runs with read N50's over 100 kilobases it demonstrated MinION is likely to be the platform of choice for those seeking highly contiguous assemblies for complex genomes.

    Abstract:

    Genome sequencing can be used to discover new pathogens but it can also be used to monitor known ones. This is known as genomic surveillance and it becoming an increasingly important tool in the response to viral outbreaks. We have demonstrated that a portable laboratory for virus sequencing can be flown to the epicentre of an ongoing outbreak and provide rapid, actionable results from the field. This avoids the delays associated with shipping samples out the country for sequencing elsewhere. We have set up mobile labs in Guinea during the 2014 West African Ebola outbreak and to Brazil during the 2015 Zika outbreak. I will talk about what goes into building a mobile lab and the ways in which they can be of use in an ongoing outbreak.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    NOV 18, 2019 08:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 08:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 8:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    Loading Comments...
    Show Resources